BRIEF-Amgen says FDA approves Blincyto

* FDA approves Blincyto(Blinatumomab) for use in pediatric

patients with Philadelphia chromosome-negative relapsed or

refractory b-cell precursor acute lymphoblastic leukemia

Source text for Eikon:...

Read more